The C3(1)/SV40 T antigen transgenic mouse model for which rapid mammary and prostate tumor development has been documented uses the FVB/N mouse as a background strain. In this study, where the background strain used was the C57BL/6J mouse, neither mammary nor prostate tumors developed over periods of up to 40 weeks. However, a disturbance of hyaline cartilage in joints was observed similar to that found in synovial chondromatosis in humans. In addition, cartilage thickening in the external ears and cartilaginous metaplasia of the ascending aorta also occurred. This suggests that rearrangement of the transgene occurred in breeding on the C57BL background, thus modifying its expression. It raises the possibility that the genetic changes induced by the SV40 T antigen transforming sequence are important in cartilage homeostasis.
INTRODUCTION
C57BL/6J-TgN(C3-1-TAg)cJeg (TAg) mice were obtained from Jackson Laboratories to generate a colony of transgenic TAg mice where hemizygous females were expected to develop mammary tumors at between 3-6 months of age and a high percentage of hemizygous males develop prostatic neoplasms (Shibata et al., 1998) . The aim was to investigate the chemopreventive efficacy of indole-3-carbinol and its major acid-catalyzed polymerization product diindolymethane against the development of mammary tumors in hemizygous females and prostate tumors in hemizygous males. Although the primary objective of this study was not achieved because mammary and prostate tumors failed to develop in any of the mice over periods of up to 40 weeks, an unusual form of pathology of articular cartilage observed in these mice is the subject of this report. Although chondrodysplasia was noted in some of the original eight founder mice of this strain, it was not fully described (Maroulakou et al., 1994) .
METHODS
Approximately 40 female and 50 male hemizygous TAg mice identified by PCR were used for the study. After weaning, at 28 days, they were all placed on a synthetic diet (AIN93G from Dyets Inc. Bethlehem, Pennsylvania 18017). They were kept for periods of up to 40 weeks when they were subjected to a full necropsy. For comparison with normal cartilage, wild-type C57BL/6J mice of analogous age (6 months) housed under similar conditions in the same laboratory were used. Animal care and procedures were conducted in accordance with the codes and practice of the Animals (Scientific Procedures) Act 1986 of the United Kingdom. A wide range of tissues from these mice was processed conventionally, sectioned and stained with hematoxylin and eosin. Tissues included liver, kidneys, salivary gland, spleen, thymus, heart, lungs, intestine, pancreas, testes, preputial gland, prostate, seminal vesicles, and in some cases external ear lobes. In addition, sternum, leg, and foot joints were also decalcified and longitudinal sections prepared. Special stains included elastic van Gieson, von Kossa for calcium and alcian blue (pH 2.5) for acid glycosaminoglycans. In addition, immunoperoxidase staining for collagen type II, the specific matrix protein of cartilage, was performed on joints, external ear, and aorta using a mouse monoclonal antibody obtained from Chemicon International (Catalogue No. MAB8887). Paraffin sections were dewaxed, taken to water, and incubated in pepsin (DAKO Code No. S3002) for 20 minutes at 37 • C.
As a negative control the primary antibody was replaced with mouse IgG1 negative control antibody (DAKO Code No. X0931). The primary antibody was detected using the peroxidase anti-peroxidase method, both the rabbit anti-mouse antibody (Code No. Z0456) and the mouse peroxidase antiperoxidase (Code No. P0850) were obtained from DAKO, the peroxidase label was visualized using 3 3 diaminobenzidine with the sections counterstained with hematoxylin. Proliferating cell nuclear antigen (PCNA) was demonstrated using a mouse monoclonal antibody clone PC10 IgG2a obtained from Novacastra (Cat No. NCL-PCNA). Sections were microwaved at 700 W in citrate at pH 6. The primary antibody was applied to the sections for 2 hr at room temperature followed by peroxidase conjugated goat anti-mouse IgG2a (Serotec Cat No. STAR 83P) for 2 hr. As a negative control the primary antibody was replaced with mouse IgG2a negative control antibody (DAKO Code No. X0943). The peroxidase label was demonstrated as described previously.
RESULTS
The growth of TAg male and female mice was comparable to those of wild-type C57BL/6J mice housed in this Vol. 32, No. 1, 2004 ARTICULAR CHONDROMATOSIS 23 laboratory and most survived to 35-40 weeks of age. However, all male and female TAg mice were identifiable by the presence of larger external ears than wild type C57BL/6J mice. Moreover, the TAg male and female mice were generally less mobile, particularly early in the day. There were no effects of treatment with the chemopreventive agents. Histological examination of the mammary glands in females showed that they were all within normal limits showing neither neoplasia nor glandular hyperplasia. Moreover, histological examination of seminal vesicles, prostate gland, testes and epididymides in males also revealed no evidence of hyperplasia or neoplasia. Likewise, liver, pancreas, intestines, salivary glands, spleen, thymus, kidney, and myocardium were unremarkable. Marked pathological changes involved the articular surfaces of the joints in the legs and feet, the cartilage of the sternum and the external ear in all animals where these tissues were examined. In addition, in at least 25% of male and female TAg mice pathological changes were observed in the ascending aorta.
The joints of the legs and feet of both males and females showed expansion of the articular cartilage, which was increased in thickness as a result of the presence of larger amounts of interstitial ground substance than in controls (Figs. 1 & 2) . At the edge of the articular surface increased numbers of enlarged nests of active chondrocytes were surrounded by dense hematoxylin staining material ( Fig. 3 ) and alcian blue staining ground substance. Many of the active chondrocytes in these zones showed nuclear labeling with the PCNA stain (Fig. 4) . The expansion of cartilage was so marked in some joints as to have provoked fusion of the joint by cartilage. Degenerative changes to cartilage were limited to those areas of marked thickening. There was no evidence of joint degeneration, significant inflammation or pannus formation and little or no hyperplasia of the synovium features usually associated with osteoarthritis. In some cases the growth of cartilage had also spread to involve the synovium lining the joint capsule and the points of insertion of adjacent tendons. By contrast, growth plate cartilage of the bone of legs and feet showed relatively little expansion, although the chondrocytes were slightly more variable in size and less regularly arranged than in wild-type C57BL/6J mice ( Figs. 1 & 2) . Similarly, cartilage rings in the airways were only slightly more irregular than comparable wild-type mice and showed a similar degree of mineralization.
The matrix of cartilage in the sternum and external ear was also expanded and contained increased numbers of chondrocytes (Figs. 5 & 6) . PCNA labeling of auricular cartilage was sparse in wild-type mice whereas foci containing increased numbers of PCNA labeled cells were seen in the cartilage of TAg mice. All areas of expanded cartilage stained for collagen type II.
In some animals the ascending aorta was characterized by cartilaginous metaplasia of the vessel wall, which was associated with the presence of alcian blue positive ground substance, degeneration, chronic inflammation, fibrosis and mineralization extending into the adventitia sometimes associated with the formation of an aneurysmal sac (Figs. 7 & 8) . Although this region of the aorta was not systematically sectioned in all animals examined, at least 25% of males and female mice were affected. Immunostaining showed the pres-ence of type II collagen within the vessel wall (Fig. 9) . The aortic valves and other cardiac valves showed no evidence of cartilaginous metaplasia or myxoid change.
DISCUSSION
The reason why these transgenic TAg mice did not develop tumors of the prostate and mammary glands over the expected time frame is not clear. Variability of response to tumor development has also been noted in other transgenic mice strains where hemizygous animals have been used (Weaver et al., 1998) . However, the background strain for which tumor development has been documented is the FVB/N mouse, raising the possibility that rearrangement of the transgene occurred in breeding on the C57BL background, thus modifying its expression.
Although this study was not designed to investigate joint pathology so joints were not examined histologically in all animals, all male and female TAg mice showed large ears, suggesting that cartilage was systematically altered in these mice. The fact that an abnormality of cartilage occurred in these mice suggests that at least some of the TAg genotype was being expressed, possibly by redirection of expression to connective tissue cells. Indeed, chondrodysplasia was noted in some of the original eight founder mice (Maroulakou et al., 1994) . Although alterations to chondrocyte differentiation have been reported in a transgenic mouse model expressing a truncated, kinase-defective TGF-β type II receptor, the changes were different to those seen in these TAg mice. Changes reported included progressive skeletal degeneration with histological evidence of joint destruction, erosions, loss of proteoglycans and synovial hyperplasia (Serra et al., 1997) , features that were not prominent in these TAg mice.
A number of mechanisms for the joint changes are plausible. The joint changes appear to be primary in nature because increased proliferation of chondrocytes was seen without significant inflammation, destructive changes or pannus formation. Moreover, the associated ear pathology also suggests that the cartilage change is not a secondary phenomenon. The Simian virus 40 large tumor antigen (TAg) is believed to functionally inactivate p53 and Rb proteins that normally lead to cellular transformation. However, cell cycle regulators of the retinoblastoma family also influence chondrocyte proliferation and differentiation (Rossi et al., 2002; Yang et al., 2003) . Moreover, a low expression of p53 protein in cartilage is linked to resistance to apoptosis and cartilage degeneration following immobilization (Okazaki et al., 2003) .
The pathological changes in the joints in these mice have features in common with synovial chondromatosis, a rare benign lesion in humans characterized by the presence of multiple nodules of abnormal cartilage in and around joints. Analogous changes have also been described in both dogs and horses (Edinger and Manley, 1998; Smith et al., 1995) . In humans, anomalies in chromosome 6 have been reported in these cases raising the possibility of a neoplastic origin for the disorder (Buddingh et al., 2003) .
Whether the cartilaginous metaplasia found in the aorta in TAg mice represents part of the same process is less clear, particularly as it was associated with active inflammation and repair and was not seen in all TAg mice. Similar changes have Fig. 6 showing detail of the wall of the aorta, in which elastic layers are interspersed by chondrocytes and blue-staining cartilaginous ground substance. H&E. ×200. 9.-Section of wall of aorta from same case as in Figs. 6 and 7 stained to show presence of cartilage-specific collagen type II. Immunoperoxidase with hematoxylin counterstain. ×200. been seen to develop in atherosclerotic plaques in the aorta of aging diabetic Apo E knockout mice (Tse et al., 1999) . It has also been recently suggested that cartilaginous metaplasia may represent a pathway which leads to arterial calcification in diabetic vascular disease in humans (Qiao et al., 2003) . It is noteworthy that the C57BL/6J mouse appears to be genetically predisposed to the development of cartilaginous metaplasia, particularly in the ascending aorta (Qiao et al., 1995) , a factor that might have also influenced the phenotype of the C57BL/6J TAg mice.
